Literature DB >> 19247295

Gearing up for follow-on biologics.

Bethan Hughes.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19247295     DOI： 10.1038/nrd2847

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

Review 1.  The FDA's assessment of follow-on protein products: a historical perspective.

Authors:  Janet Woodcock; Joseph Griffin; Rachel Behrman; Barry Cherney; Terrie Crescenzi; Blair Fraser; Dena Hixon; Christopher Joneckis; Steven Kozlowski; Amy Rosenberg; Lewis Schrager; Emily Shacter; Robert Temple; Keith Webber; Helen Winkle
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

Review 2.  Economic issues with follow-on protein products.

Authors:  Michael Lanthier; Rachel Behrman; Clark Nardinelli
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

3.  Toward biosimilar monoclonal antibodies.

Authors:  Christian K Schneider; Ulrich Kalinke
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

4.  Western biotechs ponder follow-on possibilities.

Authors:  Emily Waltz
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908
  4 in total
  6 in total

1.  Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.

Authors:  Hongwei Xie; Asish Chakraborty; Joomi Ahn; Ying Qing Yu; Deepalakshmi P Dakshinamoorthy; Martin Gilar; Weibin Chen; St John Skilton; Jeffery R Mazzeo
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 2.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

3.  2009 in reflection.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

4.  European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

Authors:  Janice M Reichert; Alain Beck; Harish Iyer
Journal:  MAbs       Date:  2009-09-25       Impact factor: 5.857

5.  5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.

Authors:  Alain Beck; Janice M Reichert; Thierry Wurch
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

6.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.